U.S. Physical Therapy (NYSE:USPH) Given New $110.00 Price Target at Barrington Research

Key Points

• Barrington Research raised its price target on U.S. Physical Therapy from $98 to $110 and maintained an “outperform” rating, implying 9.54% upside from the prior close.
• Analyst sentiment is broadly positive: MarketBeat reports a “Moderate Buy” consensus and an average price target of $101.25.
• The company beat quarterly estimates, reporting earnings of $0.80 per share and revenue of $222.56 million; revenue increased 12.9% year over year.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) had its target price boosted by Barrington Research from $98.00 to $110.00 in a note issued to investors on Friday, Benzinga reports. The firm presently has an "outperform" rating on the stock. Barrington Research's price target indicates a potential upside of 9.54% from the stock's previous close.

A number of other equities analysts have also recently weighed in on USPH. Citigroup reissued a "market outperform" rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 19th. JPMorgan Chase & Co. boosted their price target on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the company an "overweight" rating in a report on Friday, September 11th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. One analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, U.S. Physical Therapy currently has an average rating of "Moderate Buy" and a consensus price target of $101.25.

U.S. Physical Therapy Stock Performance

Shares of USPH traded up $3.22 during trading hours on Friday, reaching $100.42. 171,062 shares of the company's stock traded hands, compared to its average volume of 205,161. The firm has a market capitalization of $1.50 billion, a price-to-earnings ratio of -74.20, a P/E/G ratio of 2.27 and a beta of 1.16. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27. U.S. Physical Therapy has a twelve month low of $58.19 and a twelve month high of $101.18. The business's fifty day simple moving average is $83.78 and its two-hundred day simple moving average is $76.97.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last released its earnings results on Wednesday, November 4th. The company reported $0.80 earnings per share for the quarter, topping analysts' consensus estimates of $0.76 by $0.04. U.S. Physical Therapy had a return on equity of 10.00% and a net margin of 3.60%. The firm had revenue of $222.56 million during the quarter, compared to the consensus estimate of $214.48 million. During the same period in the prior year, the firm posted $0.66 earnings per share. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. Analysts predict that U.S. Physical Therapy will post 2.89 earnings per share for the current year.

Institutional Trading of U.S. Physical Therapy

Several hedge funds have recently added to or reduced their stakes in USPH. BlackRock Inc. bought a new stake in shares of U.S. Physical Therapy during the second quarter worth $155,505,000. Copeland Capital Management LLC lifted its position in U.S. Physical Therapy by 11.8% in the 3rd quarter. Copeland Capital Management LLC now owns 940,528 shares of the company's stock valued at $80,632,000 after acquiring an additional 98,984 shares in the last quarter. Bahl & Gaynor LLC boosted its stake in U.S. Physical Therapy by 3.2% in the 3rd quarter. Bahl & Gaynor LLC now owns 889,265 shares of the company's stock worth $76,237,000 after purchasing an additional 27,691 shares during the period. Bank of America Corp DE boosted its stake in U.S. Physical Therapy by 10.9% in the 1st quarter. Bank of America Corp DE now owns 554,621 shares of the company's stock worth $41,574,000 after purchasing an additional 54,656 shares during the period. Finally, Dimensional Fund Advisors LP boosted its stake in U.S. Physical Therapy by 3.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 507,394 shares of the company's stock worth $38,035,000 after purchasing an additional 15,668 shares during the period.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc NYSE: USPH operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.